文献速递眼底病与葡萄膜炎

基线非灌注与深部毛细血管丛缺血预测糖尿病视网膜病变两年非灌注进展

Baseline Nonperfusion and Deep Capillary Plexus Ischemia Predict Two-Year Retinal Nonperfusion Progression in Diabetic Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

一项前瞻性观察研究纳入73例(110眼)糖尿病患者,随访2年,评估超广角荧光血管造影(UWF-FA)非灌注和光学相干断层扫描血管成像(OCTA)指标对视网膜非灌注进展的预测价值。结果显示基线缺血指数是进展的最强预测因子,黄斑深部毛细血管丛(DCP)OCTA指标提供独立的非侵入性预后信息。

要点

  • 基线UWF-FA缺血指数是视网膜非灌注进展的最强预测因子。
  • 黄斑DCP几何灌注缺损和血管密度独立预测非灌注进展。
  • DCP OCTA参数可作为UWF-FA不可用时的辅助生物标志物。

核心结论

  • 基线UWF-FA非灌注是视网膜非灌注进展的最强预测因子。
  • 黄斑DCP OCTA指标提供独立的非侵入性预后信息。
  • DCP OCTA参数可作为辅助生物标志物优化DR风险分层。

研究设计与样本

  • 前瞻性观察研究,纳入73例(110眼)糖尿病患者,覆盖DR严重程度谱系。
  • 随访2年,手动量化视网膜非灌注为缺血指数。
  • 进展定义为2年缺血指数减去基线可分级视网膜的缺血指数。
  • ROC分析中,进展二分类事件定义为2年缺血指数增加超过非转诊DR平均进展的两个标准差。
  • 采用线性混合效应模型评估基线预测因子,ROC分析评估 discriminative 性能。

主要发现

  • 平均2年缺血指数进展为0.45 ± 0.90%。
  • 中度、重度非增殖性DR进展大于非转诊DR。
  • 多变量模型中,基线缺血指数(标准化β=0.27,P=0.002)独立预测总非灌注进展。
  • DCP几何灌注缺损(β=0.36,P=0.006)和DCP血管密度(β=-0.22,P=0.012)独立预测总非灌注进展。
  • 基线缺血指数、DCP几何灌注缺损、DCP血管密度检测二分类非灌注进展的AUC分别为0.84、0.77、0.70。

关键数值与推荐

  • 二分类非灌注进展定义为2年缺血指数增加超过非转诊DR平均进展的两个标准差。
  • 基线缺血指数AUC为0.84,DCP几何灌注缺损AUC为0.77,DCP血管密度AUC为0.70。

临床怎么用

  • 可利用基线UWF-FA缺血指数和OCTA黄斑DCP指标识别非灌注进展高风险患者。
  • 当UWF-FA不可用时,可考虑使用OCTA DCP参数作为辅助风险分层工具。

局限性

  • 研究样本量有限(73例,110眼),结论需更大队列验证。
  • 非灌注进展定义基于非转诊DR平均进展的两个标准差,可能受参考人群影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to determine which baseline factors, including ultra-widefield fluorescein angiography (UWF-FA) nonperfusion and macular optical coherence tomography angiography (OCTA) metrics, predict 2-year progression of retinal nonperfusion on UWF-FA in diabetic retinopathy (DR). METHODS: This prospective observational study included 73 patients (110 eyes) with diabetes across the spectrum of DR severity, followed for 2 years. Retinal nonperfusion was manually quantified as ischemic index, and progression was calculated as the 2-year minus baseline ischemic index for gradable retina. For receiver operating characteristic (ROC) analyses, progression was further defined as a binary event when the 2-year ischemic index increase exceeded two standard deviations (SDs) above the mean progression observed in non-referable DR. Linear mixed-effects models evaluated baseline predictors, and ROC analyses assessed the discriminative performance of significant predictors. RESULTS: Mean 2-year ischemic index progression was 0.45 ± 0.90%, with greater progression in moderate and severe nonproliferative DR than in non-referable DR. In multivariate models, greater baseline ischemic index (standardized β = 0.27, P = 0.002), higher deep capillary plexus (DCP) geometric perfusion deficit (β = 0.36, P = 0.006), and lower DCP vessel density (β = -0.22, P = 0.012) independently predicted total nonperfusion progression. Baseline ischemic index, DCP geometric perfusion deficit, and DCP vessel density yielded areas under the curve of 0.84, 0.77, and 0.70, respectively, for detecting binary nonperfusion progression. CONCLUSIONS: In this cohort, baseline UWF-FA nonperfusion was the strongest predictor of retinal nonperfusion progression, whereas macular DCP OCTA metrics provided independent, noninvasive prognostic information. Macular DCP OCTA parameters may serve as adjunctive biomarkers to refine DR risk stratification, particularly when UWF-FA is unavailable.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Busza AM, Kakihara S, Zhuang K, et al. Baseline Nonperfusion and Deep Capillary Plexus Ischemia Predict Two-Year Retinal Nonperfusion Progression in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2026. PMID: 41615369. doi:10.1167/iovs.67.1.64

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。